Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Leukemia

  Free Subscription


Articles published in J Natl Cancer Inst

Retrieve available abstracts of 12 articles:
HTML format



Single Articles


    June 2022
  1. KEATING NL, Brooks GA, Landrum MB, Liu PH, et al
    The Oncology Care Model and Adherence to Oral Cancer Drugs: A Difference-in-Differences Analysis.
    J Natl Cancer Inst. 2022;114:871-877.
    PubMed     Abstract available


    May 2022
  2. ZHAO X, Qian M, Goodings C, Zhang Y, et al
    Molecular mechanisms of ARID5B-mediated genetic susceptibility to acute lymphoblastic leukemia.
    J Natl Cancer Inst. 2022 May 16. pii: 6586299. doi: 10.1093.
    PubMed     Abstract available


  3. RODWIN RL, Kairalla JA, Hibbitts E, Devidas M, et al
    Persistence of chemotherapy-induced peripheral neuropathy despite vincristine reduction in childhood b-acute lymphoblastic leukemia.
    J Natl Cancer Inst. 2022 May 12. pii: 6584828. doi: 10.1093.
    PubMed     Abstract available


    March 2022
  4. GARCIA-PRIETO CA, Villanueva L, Bueno-Costa A, Davalos V, et al
    Epigenetic Profiling and Response to CD19 Chimeric Antigen Receptor T-Cell Therapy in B-Cell Malignancies.
    J Natl Cancer Inst. 2022;114:436-445.
    PubMed     Abstract available


    October 2021
  5. LIPSYC-SHARF M, Zhang S, Ou FS, Ma C, et al
    Survival in Young-Onset Metastatic Colorectal Cancer: Findings from Cancer and Leukemia Group B (Alliance)/SWOG 80405.
    J Natl Cancer Inst. 2021 Oct 12. pii: 6390822. doi: 10.1093.
    PubMed     Abstract available


    September 2021
  6. EFFICACE F, Baccarani M
    Quality of Life Improvements in Patients with Chronic Myeloid Leukemia after Stopping Long-Term Therapy: Who Can Benefit the Most?
    J Natl Cancer Inst. 2021 Sep 7. pii: 6365945. doi: 10.1093.
    PubMed    


  7. SCHOENBECK KL, Atallah E, Lin L, Weinfurt KP, et al
    Patient-Reported Functional Outcomes in Patients with Chronic Myeloid Leukemia after Stopping Tyrosine Kinase Inhibitors.
    J Natl Cancer Inst. 2021 Sep 7. pii: 6365943. doi: 10.1093.
    PubMed     Abstract available


    May 2021
  8. VAN DER PLAS E, Qiu W, Nieman BJ, Yasui Y, et al
    Sex-Specific Associations Between Chemotherapy, Chronic Conditions, and Neurocognitive Impairment in Acute Lymphoblastic Leukemia Survivors: A Report From the Childhood Cancer Survivor Study.
    J Natl Cancer Inst. 2021;113:588-596.
    PubMed     Abstract available


    October 2020
  9. DUSETZINA SB, Huskamp HA, Jazowski SA, Winn AN, et al
    Oral Oncology Parity Laws, Medication Use, and Out-of-Pocket Spending for Patients With Blood Cancers.
    J Natl Cancer Inst. 2020;112:1055-1062.
    PubMed     Abstract available


    September 2020
  10. ZHANG H, Liu AP, Devidas M, Lee SHR, et al
    Association of GATA3 polymorphisms with minimal residual disease and relapse risk in childhood acute lymphoblastic leukemia.
    J Natl Cancer Inst. 2020 Sep 7. pii: 5902455. doi: 10.1093.
    PubMed     Abstract available


  11. LEE SHR, Qian M, Yang W, Diedrich JD, et al
    Genome-wide association study of susceptibility loci for TCF3-PBX1 acute lymphoblastic leukemia in children.
    J Natl Cancer Inst. 2020 Sep 3. pii: 5901054. doi: 10.1093.
    PubMed     Abstract available


    August 2020
  12. STEFANSKI KJ, Anixt JS, Goodman P, Bowers K, et al
    Long-Term Neurocognitive and Psychosocial Outcomes After Acute Myeloid Leukemia: A Childhood Cancer Survivor Study Report.
    J Natl Cancer Inst. 2020 Aug 14. pii: 5892765. doi: 10.1093.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: